How The Ocugen (OCGN) Story Is Shifting With Gene Therapy Milestones And Valuation Debate [Yahoo! Finance]
Ocugen, Inc. (OCGN)
Company Research
Source: Yahoo! Finance
Ocugen's latest analyst update keeps the central fair value estimate at US$11.57, while published price targets from different firms span US$10, US$12 and US$22. That spread reflects contrasting views on the company's gene therapy pipeline, with some analysts focusing on recent OCU410 and OCU400 data and BLA timelines, and others stressing execution, safety and financing risks. Looking ahead, you will see how this mix of steady fair value, widely ranged targets and new clinical milestones is shaping the story investors are watching. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Ocugen. What Wall Street Has Been Saying ?? Bullish Takeaways Lucid Capital lifted its Ocugen target to US$22 from US$15 after positive preliminary Phase 2 OCU410 data in geographic atrophy, signaling confidence that recent clinical readouts support a higher valuation range. Oppenheimer started coverage with a US$10 target, highli
Show less
Read more
Impact Snapshot
Event Time:
OCGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCGN alerts
High impacting Ocugen, Inc. news events
Weekly update
A roundup of the hottest topics
OCGN
News
- Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results [Yahoo! Finance]Yahoo! Finance
- Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial ResultsGlobeNewswire
- Ocugen to Present at April 2026 Investor and Industry ConferencesGlobeNewswire
- Ocugen (OCGN) Valuation Check After Encouraging Phase 2 ArMaDa Results For OCU410 [Yahoo! Finance]Yahoo! Finance
- OCU410's Phase 2 Gene-Agnostic Results in Dry AMD Might Change The Case For Investing In Ocugen (OCGN) [Yahoo! Finance]Yahoo! Finance
OCGN
Earnings
- 3/4/26 - In-Line
OCGN
Sec Filings
- 4/28/26 - Form DEFA14A
- 4/28/26 - Form DEF
- 4/28/26 - Form ARS
- OCGN's page on the SEC website